View source for Doxorubicin decreases medicine level of resistance involving SCLC cells by simply suppressing the actual inflamation related microenvironment as well as the STAT3VEGF pathway
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.